Dermatofibrosarcoma protuberans of the vulva: report of two new cases and review of the literature.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 25950561)

Published in J Low Genit Tract Dis on April 01, 1999

Authors

M G Zlatnik1, T V Dinh, J A Lucci, E V Hannigan

Author Affiliations

1: Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Galveston, TX.

Articles by these authors

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med (1996) 5.56

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol (1999) 5.53

Primary vaginal melanoma: improved survival with radical pelvic surgery. Gynecol Oncol (1994) 2.14

Adenovirus-based p53 gene therapy in ovarian cancer. Gynecol Oncol (1995) 1.49

A phase II trial of neoadjuvant chemotherapy prior to radical hysterectomy and/or radiation therapy in the management of advanced carcinoma of the uterine cervix. Gynecol Oncol (1995) 1.44

A decrease from 8 to 6 weeks in obstetrics and gynecology clerkship: effect on medical students' cognitive knowledge. Obstet Gynecol (1995) 1.39

Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients. Proc Natl Acad Sci U S A (1990) 1.34

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. J Clin Oncol (1992) 1.26

4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci U S A (1995) 1.15

Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group study. Cancer (1993) 1.14

Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer. J Cancer Res Clin Oncol (1997) 1.12

Enterobius vermicularis salpingitis: a distant episode from precipitating appendicitis. Obstet Gynecol (1992) 1.09

Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest (1998) 1.07

Endometriosis occurring in leiomyomatosis peritonealis disseminata: ultrastructural study and histogenetic consideration. Am J Surg Pathol (1980) 0.99

Prenatal diagnosis of recurrence of Saldino-Noonan dwarfism. J Pediatr (1977) 0.98

Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats. J Immunother (1991) (1991) 0.97

Uterine leiomyosarcoma. Am J Obstet Gynecol (1979) 0.90

Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix. Obstet Gynecol (1996) 0.90

Epithelial ovarian neoplasms of low malignant potential. Gynecol Oncol (1985) 0.88

Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer. Horm Metab Res (2011) 0.87

Tumor board in gynecologic oncology. Int J Gynecol Cancer (2004) 0.87

Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study. J Clin Oncol (1987) 0.86

Cone biopsy during pregnancy. Obstet Gynecol (1982) 0.85

Long-term survival with metastatic uterine sarcoma. N Y State J Med (1985) 0.84

Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%. Clin Cancer Res (2001) 0.84

A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers. Int J Gynecol Cancer (2006) 0.84

Adjuvant chemotherapy in early uterine sarcoma. Gynecol Oncol (1983) 0.84

Angiogenin, interleukins, and growth-factor levels in serum of patients with ovarian cancer: correlation with angiogenesis. Cancer J Sci Am (2006) 0.83

To drain or not to drain: a retrospective study of closed-suction drainage following radical hysterectomy with pelvic lymphadenectomy. Gynecol Oncol (1993) 0.83

Evaluation of amonafide in cervical cancer, phase II. A SWOG study. Am J Clin Oncol (1992) 0.82

A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix--a Gynecologic Oncology Group Study. Invest New Drugs (2001) 0.82

Outpatient loop electrosurgical excision procedure for cervical intraepithelial neoplasia. Can it replace cold knife conization? J Reprod Med (1996) 0.82

Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix. Obstet Gynecol (1993) 0.82

Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer. J Clin Endocrinol Metab (1988) 0.81

Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy--a randomized phase II study by theSouthwest Oncology Group. Gynecol Oncol (1996) 0.81

Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer. A Southwest Oncology Group study. Am J Clin Oncol (1990) 0.81

Ureteroarterial fistula. J Obstet Gynaecol (2012) 0.81

Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix. J Reprod Med (1999) 0.80

Treatment of advanced uterine sarcoma with adriamycin. Gynecol Oncol (1983) 0.79

Mixed müllerian tumors of the uterus: a clinicopathologic study. Obstet Gynecol (1989) 0.79

Cervical cancer, a major killer of Hispanic women: implications for health education. Health Educ (1989) 0.79

Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamide. Gynecol Oncol (1983) 0.79

Management of patients with positive margins after cervical conization. Obstet Gynecol (1993) 0.79

Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326). Gynecol Oncol (2001) 0.79

The effect of naproxen on fever in patients with advanced gynecologic malignancies. Gynecol Oncol (1995) 0.78

A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study. Gynecol Oncol (1990) 0.78

Carcinoma in situ of the vulva. A clinicopathologic study of 50 cases. J Reprod Med (1986) 0.78

Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group study. Gynecol Oncol (1999) 0.78

Bone metastasis in epithelial ovarian carcinoma. Int J Gynaecol Obstet (1996) 0.78

Prognostic nutritional index in relation to hospital stay in women with gynecologic cancer. Obstet Gynecol (2000) 0.77

Benign adrenal cyst presenting in a pregnant patient. Am J Perinatol (1997) 0.77

Human papillomavirus testing for triage in a referral population. J Low Genit Tract Dis (2001) 0.77

Three-dimensional endothelial-tumor epithelial cell interactions in human cervical cancers. In Vitro Cell Dev Biol Anim (1997) 0.77

XY gonadal dysgenesis with gonadoblastoma and dysgerminoma. South Med J (1984) 0.77

The cytologist and bacterioses of the vaginal-ectocervical area. Clues, commas and confusion. Acta Cytol (1989) 0.77

Does glutamine supplementation increase radioresistance in squamous cell carcinoma of the cervix? Gynecol Oncol (1998) 0.76

Primary lung choriocarcinoma masquerading as a metastatic gestational neoplasm. Gynecol Oncol (1994) 0.76

MR imaging of uterine cervical carcinoma. J Comput Assist Tomogr (1988) 0.75

Treatment of human papillomavirus-associated vulvar disease with the CO2-laser. Physical and histological aspects with use of a new scanning device, the SwiftLase. Arch Gynecol Obstet (1996) 0.75

17 alpha-hydroxylase deficiency in genetic females. A report of two cases. J Reprod Med (1986) 0.75

Management of cervical intraepithelial neoplasia during pregnancy: a simplified and cost-effective approach. J Low Genit Tract Dis (1998) 0.75

Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group Study. Gynecol Oncol (1987) 0.75

Surgical blood loss in abdominal hysterectomy. Gynecol Oncol (2001) 0.75

Hyperthecosis of the ovaries in a woman with a placental site trophoblastic tumor. Obstet Gynecol (1990) 0.75

Bleomycin, vincristine, and methotrexate with citrovorum factor rescue in the treatment of advanced squamous cell carcinoma of the cervix. Gynecol Oncol (1984) 0.75

Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer. Lymphokine Cytokine Res (1991) 0.75

Chronic plasma cell cervicitis simulating a cervical malignancy: a case report. Obstet Gynecol (1993) 0.75

Simultaneously occurring condylomata acuminata, carcinoma in situ and verrucous carcinoma of the vulva and carcinoma in situ of the cervix in a young woman. A case report. J Reprod Med (1988) 0.75

Effect of hemodilution on tissue perfusion and blood coagulation during radical hysterectomy. Gynecol Oncol (2001) 0.75

Papanicolaou smears of atypical glandular cells of undetermined significance: histological correlations and suggestions for management. J Low Genit Tract Dis (1999) 0.75

Flow cytometry in cervical adenocarcinoma. Correlating DNA content analysis with the clinical picture. J Reprod Med (1997) 0.75

Mixed mesodermal tumors of the ovary: a clinicopathologic study of 14 cases. Obstet Gynecol (1988) 0.75

Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group Study. Gynecol Oncol (1987) 0.75

MRI of cervical carcinoma. Semin Ultrasound CT MR (1988) 0.75

Frozen section evaluation of cervical conization specimens. J Reprod Med (1986) 0.75

A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial. Gynecol Oncol (1990) 0.75

Correlation of the Digene HPV Assay Hybrid Capture System with Colposcopically Guided Biopsy Results. J Low Genit Tract Dis (1999) 0.75

Hormonal studies on adrenal-like tumor of the ovary--considerations on its histogenesis. Am J Clin Pathol (1986) 0.75

Necessity of endocervical curettage in colposcopy. Am J Obstet Gynecol (1986) 0.75

Conservative management of positive resection margins after loop electrosurgical excision procedure. J Low Genit Tract Dis (1998) 0.75

A phase II trial of amonafide in patients with nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Am J Clin Oncol (1997) 0.75

Trafficking of syngeneic murine lymphokine activated killer T cells following intraperitoneal administration in normal and tumor bearing mice. Gynecol Oncol (1992) 0.75

Lower genital tract metastases of placental site trophoblastic tumor: case report and review of the literature. J Low Genit Tract Dis (2000) 0.75

Necessity for endocervical curettage in elderly women undergoing colposcopy. J Reprod Med (1989) 0.75

Phase I studies of continuous-infusion paclitaxel given with standard aggressive radiation therapy for locally advanced solid tumors. Semin Oncol (1995) 0.75

Electromyographic study of the function of some muscles crossing the glenohumeral joint. Arch Phys Med Rehabil (1969) 0.75